AIPLA Amicus Brief in GSK v. USPTO.
The American Intellectual Property Law Association (AIPLA), feeling pressure from its membership, filed an amicus brief yesterday with the E.D. Virginia in support of GSK’s challenge to the new USPTO claims and continuations rules.
The brief focuses primarily on the irreparable harm that the rules will cause, both in signficant loss of patent rights and in compliance costs.
A copy of the brief is available via the PLI Blog here.